Status:

RECRUITING

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

Lead Sponsor:

Jasper Gerritsen

Collaborating Sponsors:

Haaglanden Medical Centre

Universitaire Ziekenhuizen KU Leuven

Conditions:

Glioblastoma

High-grade Glioma

Eligibility:

All Genders

18-90 years

Brief Summary

A greater extent of resection of the contrast-enhancing (CE) tumor part has been associated with improved outcomes in high-grade glioma patients. Recent results suggest that resection of the non-contr...

Detailed Description

This is an international, multicenter, prospective, observational, 2-arm cohort study (registration: clinicaltrials.gov ID number TBA). Eligible patients are operated with supramaximal resection versu...

Eligibility Criteria

Inclusion

  • Age ≥18 years and ≤90 years
  • Tumor diagnosed as HGG (WHO grade III/IV) on MRI as assessed by the neurosurgeon
  • Written informed consent

Exclusion

  • Tumors of the cerebellum, brainstem or midline
  • Multifocal contrast enhancing lesions
  • Medical reasons precluding MRI (e.g. pacemaker)
  • Inability to give written informed consent
  • Secondary high-grade glioma due to malignant transformation from low-grade glioma
  • Second primary malignancy within the past 5 years with the exception of adequately treated in situ carcinoma of any organ or basal cell carcinoma of the skin

Key Trial Info

Start Date :

January 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2028

Estimated Enrollment :

784 Patients enrolled

Trial Details

Trial ID

NCT06118723

Start Date

January 1 2022

End Date

January 1 2028

Last Update

February 22 2024

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

University of California, San Francisco (UCSF)

San Francisco, California, United States, 94143

2

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

3

University Hospitals Leuven

Leuven, Belgium, 3000

4

Universitätsklinikum Heidelberg

Heidelberg, Baden-Wurttemberg, Germany, 69120

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) | DecenTrialz